InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,187.70
(
0.13%
)
US TECH 100
17,617.63
(
0.04%
)
Dow Jones
38,884.26
(
0.08%
)
Brent Oil
82.84
(
-0.04%
)
Bitcoin
62,532.46
(
0.32%
)
Post# of 181
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

36Knuckle

Send PM Follow Ignore
Followers 23
Posts 3092
Boards Moderated 1
Alias Born 04/29/2019

36Knuckle

Re: None

Tuesday, 10/06/2020 11:02:22 AM

Tuesday, October 06, 2020 11:02:22 AM

Post# of 181
Just passing through...
"This morning, Canaccord released a flash update for Mind Medicine (NEO: MMED) with highlights from the recent two-day virtual non-deal roadshow that was hosted by Canaccord Genuity, which included JR Rahn and Stephen Hurst, co-CEOs of MMED, and Dr. Miri Halperin Wernli, who heads up MindMed Discovery. Canaccord’s analyst Tania Gonsalves reiterated their 12-month price target of C$1.75 and their Speculative Buy recommendation on the company".
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up